HOME >> MEDICINE >> NEWS
New drug boost for asbestos-related lung cancer sufferers

Clinical trials of a new anticancer drug combination carried out by researchers at Newcastle University show that it has potential to almost double the life expectancy of sufferers of Mesothelioma a form of lung cancer which affects around 1,700 people in the UK every year according to a report published in the Journal of Clinical Oncology.

Mesothelioma is a cancer of the pleura the membranes that lines the inside of the chest and the outside of the lungs. It differs from other types of lung cancer in that it is caused by exposure to asbestos, rather than by smoking. The condition affects five times more men than women, and most commonly develops in men between 50 and 70 years of age.

Mesothelioma is very hard to treat. It is usually inoperable and not very responsive to radiotherapy. With the anticancer drugs previously available, people diagnosed with the disease could expect to survive for only six to eight months.

Now, results of a study by Professor Hilary Calvert, Dr Andrew Hughes and colleagues in the Cancer Research UK-funded Cancer Research Unit at Newcastle University, in collaboration in Eli Lilley, have shown that, on average, patients who were given the new drug, pemetrexed and carboplatin, survived for up to 13 14 months. In a handful of cases, patients have survived for three years or more.

Professor Calvert said: 'The drug combination showed remarkable activity in Mesothelioma. Indeed, our study provided the first convincing demonstration that pemetrexed to carboplatin could be useful in the treatment of the disease'.

Pemetrexed is an experimental drug being developed by pharmaceutical company Eli Lilley under the trade name Alimta. It is an anticancer drug based on being an analogue of the B-vitamin, folic acid. Drugs of this class were first developed by Professor Calvert and colleagues at the Institute of Cancer Research in London in the early 1980s with funding from Cancer Research, leading to the l
'"/>

Contact: Prof. Hilary Calvert
44-191-222-8057
University of Newcastle upon Tyne
13-Aug-2002


Page: 1 2

Related medicine news :

1. Daily supplement may boost birthweight of babies in the developing world
2. $4 million grant boosts University of Michigan campaign for a new childrens hospital
3. UC Irvines undergraduate research programs receive $900,000 funding boost
4. Calcium boost to youths bones could reduce osteoporosis risk
5. Collaborative care, training boosts adolescent depression treatment in primary care clinics
6. NIAID-sponsored clinical trial aims to boost flu vaccine supply
7. Novel p53 gene-based therapy boosts immune system and reduces tumor size
8. Multi-center study finds therapy boosts kidney transplants in highly sensitized patients
9. Sleep loss boosts appetite, may encourage weight gain
10. Intervention boosts activity in kids, especially minorities
11. Advanced, precise radiation may boost limb-sparing therapy for sarcoma

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance Group, ... Dallas, Miami, and Raleigh regions, is organizing an extended charity drive to benefit ... deadly chromosome abnormality. , After struggling since birth with several health challenges, T.J. ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... the certification process to promote standards of excellence for the field of eating ... for March 22 – 25, 2018 in Orlando, Florida at the Omni Resort ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob ... sciatica in a new episode of "Success Files," which is an award-winning educational ... and investigates each subject in-depth with passion and integrity. , Sciatica occurs when ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
Breaking Medicine News(10 mins):
(Date:10/7/2017)... , Oct. 6, 2017   Provista, ... more than $100 billion in purchasing power, today announced ... and information. The Newsroom is the online ... industry trends, infographics, expert bios, news releases, slideshows and ... access to a wealth of resources at their fingertips, ...
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, Inc. ... Day Software and Consulting, LLC , and named its ... Software, based in Tennessee , will ... Day expands EnvoyHealth,s service offerings for health care partners ... "In an interoperable world, ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
Breaking Medicine Technology:
Cached News: